Clinical trial

Osmotin Plant Protein for Progressive Multiple Sclerosis

NCT05937802

StatusUNKNOWN
Study typeINTERVENTIONAL
Start date2023-01-02
PhaseNA

Study timeline

Study start (actual)2023-01-02Date precision: day
Registry last updated2023-07-10
Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Interventions

OsmotinDIETARY_SUPPLEMENT

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.